Tumor antigen (including mutated neoantigens, cancer germline antigens, and viral antigens)-specific T cells can be obtained from both tumor tissues and autologous peripheral blood from CD8+PD-1+ cell populations (at frequencies of about 0.4–0.002% in blood) [80–82]. Here, CD8A is linked to cancer.